Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Drug Alcohol Depend. 2018 Jan 12;184:48–56. doi: 10.1016/j.drugalcdep.2017.11.020

Figure 2.

Figure 2

Significant differences in secondary Go/NoGo task outcomes among early onset smokers (EOS), late onset smokers (LOS), and healthy non-smokers (HNS) are shown. (A) Group differences in smoking-related ‘NoGo’ trial accuracy. (B) Group differences in neutral ‘NoGo’ trial accuracy. (C) Group differences in neutral ‘Go’ trial accuracy. (D) Group differences in smoking ‘NoGo’ response reaction time. (E) Group differences in neutral ‘NoGo’ response reaction time. All values are the means ± SD. ** p≤0.03, relative to LOS and HNS. * p≤0.05, relative to HNS.